Concern regarding the safety of tumor necrosis factor-alfa antagonists in pregnancy.
Andrew
A
Miner
D000014:Abnormalities, Drug-Induced / Q000209:etiology*; D000911:Antibodies, Monoclonal / Q000009:adverse effects*; D000068800:Etanercept; D005260:Female; D006801:Humans; D007074:Immunoglobulin G / Q000009:adverse effects*; D000069285:Infliximab; D011247:Pregnancy; D018124:Receptors, Tumor Necrosis Factor; D012449:Safety; D014409:Tumor Necrosis Factor-alpha / Q000037:antagonists & inhibitors*
D000911:Antibodies, Monoclonal; D007074:Immunoglobulin G; D018124:Receptors, Tumor Necrosis Factor; D014409:Tumor Necrosis Factor-alpha; D000069285:Infliximab; D000068800:Etanercept